Heart Rate Variability in Hyperthyroidism: A Systematic Review and Meta-Analysis.

autonomic nervous activity biomarker prevention public health thyroid

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
18 03 2022
Historique:
received: 16 02 2022
revised: 16 03 2022
accepted: 16 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 19 4 2022
Statut: epublish

Résumé

Objective: Cardiovascular effects of thyroid hormones may be measured through heart rate variability (HRV). We sought to determine the impact of hyperthyroidism on HRV. Design: A systematic review and meta-analysis on the impact of hyperthyroidism on HRV. Methods: PubMed, Cochrane, Embase and Google Scholar were searched until 20 August 2021 for articles reporting HRV parameters in untreated hyperthyroidism and healthy controls. Random-effects meta-analysis was stratified by degree of hyperthyroidism for each HRV parameter: RR intervals (or Normal-to-Normal intervals—NN), SDNN (standard deviation of RR intervals), RMSSD (square root of the mean difference of successive RR intervals), pNN50 (percentage of RR intervals with >50 ms of variation), total power (TP), LFnu (low-frequency normalized unit) and HFnu (high-frequency), VLF (very low-frequency), and LF/HF ratio. Results: We included 22 studies with 10,811 patients: 1002 with hyperthyroidism and 9809 healthy controls. There was a decrease in RR (effect size = −4.63, 95% CI −5.7 to −3.56), SDNN (−6.07, −7.42 to −4.71), RMSSD (−1.52, −2.18 to −0.87), pNN50 (−1.36, −1.83 to −0.88), TP (−2.05, −2.87 to −1.24), HFnu (−3.51, −4.76 to −2.26), and VLF power (−2.65, −3.74 to −1.55), and an increase in LFnu (2.66, 1.55 to 3.78) and LF/HF ratio (1.75, 1.02 to 2.48) (p < 0.01). Most parameters had ES that was twice as high in overt compared to subclinical hyperthyroidism. Increased peripheral thyroid hormones and decreased TSH levels were associated with lower RR intervals. Conclusions: Hyperthyroidism is associated with a decreased HRV, which may be explained by the deleterious effect of thyroid hormones and TSH. The increased sympathetic and decreased parasympathetic activity may have clinical implications.

Identifiants

pubmed: 35329294
pii: ijerph19063606
doi: 10.3390/ijerph19063606
pmc: PMC8949365
pii:
doi:

Substances chimiques

Thyrotropin 9002-71-5

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Références

Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Psychophysiology. 2016 Jun;53(6):951-7
pubmed: 26934635
BMJ Open. 2015 Feb 20;5(2):e007716
pubmed: 25710916
Braz J Med Biol Res. 2012 Jul;45(7):591-600
pubmed: 22510779
Int J Cardiol. 1998 Apr 1;64(2):145-51
pubmed: 9688433
Heart Fail Rev. 2000 Mar;5(1):57-71
pubmed: 16228916
Clin Endocrinol (Oxf). 2007 Aug;67(2):290-4
pubmed: 17524031
Circulation. 2007 Oct 9;116(15):1725-35
pubmed: 17923583
Hypertension. 2003 Dec;42(6):1106-11
pubmed: 14581296
Sports Med. 2017 Jan;47(1):163-173
pubmed: 27328852
Eur Rev Med Pharmacol Sci. 2015;19(9):1689-95
pubmed: 26004610
Curr Hypertens Rep. 2008 Dec;10(6):440-7
pubmed: 18959829
Am J Phys Anthropol. 2006 Jan;129(1):151-6
pubmed: 16270304
BMC Res Notes. 2018 Feb 22;11(1):151
pubmed: 29471876
J Clin Endocrinol Metab. 1994 May;78(5):1026-7
pubmed: 8175954
Annu Int Conf IEEE Eng Med Biol Soc. 2008;2008:1988-91
pubmed: 19163082
Am J Cardiol. 2004 Aug 15;94(4):465-9
pubmed: 15325930
Am J Physiol Endocrinol Metab. 2001 Jul;281(1):E190-5
pubmed: 11404237
Indian J Clin Biochem. 2018 Apr;33(2):222-228
pubmed: 29651216
Thyroid. 2012 May;22(5):454-60
pubmed: 22510014
Blood Press. 2017 Dec;26(6):350-358
pubmed: 28738697
Am J Hypertens. 1989 Mar;2(3 Pt 2):112S-118S
pubmed: 2647101
Am J Med. 1990 Jun;88(6):642-6
pubmed: 2189309
Biomed Pharmacother. 2010 Oct;64(8):546-9
pubmed: 20650598
Thyroid. 1991;1(2):137-41
pubmed: 1688015
Eur J Clin Invest. 2019 Nov;49(11):e13174
pubmed: 31560809
Physiol Meas. 2007 Apr;28(4):427-37
pubmed: 17395997
Am J Physiol Heart Circ Physiol. 2001 May;280(5):H2061-8
pubmed: 11299207
Braz J Med Biol Res. 2018 Aug 27;51(11):e7704
pubmed: 30156596
Eur Heart J. 1996 Mar;17(3):354-81
pubmed: 8737210
Rev Port Cardiol. 2017 Jul - Aug;36(7-8):499-508
pubmed: 28687367
Am J Med. 1983 Aug;75(2):249-58
pubmed: 6881176
Lancet. 2001 Sep 15;358(9285):861-5
pubmed: 11567699
J Clin Endocrinol Metab. 1976 Jan;42(1):125-31
pubmed: 1249180
Eur J Intern Med. 2005 Feb;16(1):12-20
pubmed: 15733815
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Psychoneuroendocrinology. 2008 Nov;33(10):1305-12
pubmed: 18819754
Am J Physiol Heart Circ Physiol. 2001 Mar;280(3):H1081-7
pubmed: 11179050
J Pak Med Assoc. 2012 May;62(5):422-5
pubmed: 22755301
J Am Coll Cardiol. 1996 Nov 15;28(6):1539-46
pubmed: 8917269
J Appl Physiol (1985). 1996 Aug;81(2):743-50
pubmed: 8872642
Diabetes Technol Ther. 2016 Jun;18(6):366-76
pubmed: 27258123
Circulation. 1993 May;87(5):1435-41
pubmed: 8490997
BMJ. 2001 Aug 11;323(7308):334-6
pubmed: 11498496
Circulation. 1992 Jan;85(1):164-71
pubmed: 1728446
Front Public Health. 2017 Sep 11;5:240
pubmed: 28955705
Eur J Endocrinol. 2001 Dec;145(6):691-6
pubmed: 11720892
BMJ. 2010 Mar 23;340:c869
pubmed: 20332511
Indian Pacing Electrophysiol J. 2005 Oct 01;5(4):305-11
pubmed: 16943880
Clin Sci (Lond). 1987 Feb;72(2):239-44
pubmed: 3816080
Circ Res. 2014 May 23;114(11):1815-26
pubmed: 24855204
J Am Coll Cardiol. 1993 Mar 1;21(3):729-36
pubmed: 8436755
Niger J Clin Pract. 2019 Oct;22(10):1349-1355
pubmed: 31607723
J Clin Invest. 1989 Mar;83(3):803-9
pubmed: 2537849
Life Sci. 2010 Jan 30;86(5-6):153-7
pubmed: 19958777
Lancet. 1998 Feb 14;351(9101):478-84
pubmed: 9482439
Front Public Health. 2017 Sep 28;5:258
pubmed: 29034226
Circulation. 1993 Jul;88(1):180-5
pubmed: 8319331
Int J Clin Pract. 2014 May;68(5):533-4
pubmed: 24750523
Handb Clin Neurol. 2013;117:379-93
pubmed: 24095141
J Clin Endocrinol Metab. 2014 Mar;99(3):923-31
pubmed: 24423323
Biostatistics. 2000 Sep;1(3):247-62
pubmed: 12933507
J Clin Epidemiol. 2001 Oct;54(10):1046-55
pubmed: 11576817
Sports Med. 2015 Sep;45(9):1285-1294
pubmed: 25946994
Int Heart J. 2014;55(1):33-8
pubmed: 24463923
J Strength Cond Res. 2011 Aug;25(8):2304-10
pubmed: 21691230
Indian Heart J. 2017 Jul - Aug;69(4):545-550
pubmed: 28822529
J Clin Endocrinol Metab. 1996 Aug;81(8):2828-35
pubmed: 8768838
Cas Lek Cesk. 2007;146(5):497-502
pubmed: 17554975
Ann Intern Med. 2002 Nov 5;137(9):753-63
pubmed: 12416949
PLoS One. 2016 Dec 1;11(12):e0166915
pubmed: 27907028
J Clin Endocrinol Metab. 2008 Jul;93(7):2835-41
pubmed: 18397977
Circulation. 2000 Sep 12;102(11):1239-44
pubmed: 10982537
Int Heart J. 2008 Mar;49(2):175-81
pubmed: 18475017
N Engl J Med. 1997 Aug 21;337(8):536-42
pubmed: 9262498
Indian J Physiol Pharmacol. 2009 Jul-Sep;53(3):243-52
pubmed: 20329371
Korean J Intern Med. 2018 Mar;33(2):277-283
pubmed: 29277096
Clin Exp Hypertens. 2018;40(3):251-256
pubmed: 28872359
Eur Heart J. 2004 Jul;25(14):1242-8
pubmed: 15246643
J Endocrinol Invest. 2004 Apr;27(4):348-52
pubmed: 15233554
J Clin Endocrinol Metab. 2002 Feb;87(2):489-99
pubmed: 11836274
Front Psychol. 2017 Jan 27;8:64
pubmed: 28191002
Heart. 1997 Oct;78(4):371-5
pubmed: 9404253
BMC Res Notes. 2018 Nov 15;11(1):814
pubmed: 30442195
Endocr Rev. 2005 Aug;26(5):704-28
pubmed: 15632316
Clin Endocrinol (Oxf). 2006 Jun;64(6):611-6
pubmed: 16712661
Auton Neurosci. 2018 Sep;213:86-91
pubmed: 30005745
Eur J Prev Cardiol. 2017 Feb;24(3):281-296
pubmed: 27856807
Ann N Y Acad Sci. 1993 Dec 31;703:135-46; discussion 146-8
pubmed: 8192291
J Am Coll Cardiol. 2002 Jan 16;39(2):366-72
pubmed: 11788233
Chest. 2014 Jun;145(6):1339-1346
pubmed: 24480869
Ann Noninvasive Electrocardiol. 2005 Jan;10(1):88-101
pubmed: 15649244
J Am Coll Cardiol. 1998 Mar 1;31(3):593-601
pubmed: 9502641
J Cardiovasc Nurs. 2002 Oct;17(1):69-81
pubmed: 12358094
PLoS One. 2016 Jun 03;11(6):e0156431
pubmed: 27257676
J Clin Endocrinol Metab. 2000 Jan;85(1):159-64
pubmed: 10634380
Indian J Physiol Pharmacol. 2003 Apr;47(2):164-70
pubmed: 15255619
J Clin Endocrinol Metab. 1996 Dec;81(12):4224-8
pubmed: 8954019

Auteurs

Valentin Brusseau (V)

Endocrinology Diabetology and Metabolic Diseases, CHU Clermont-Ferrand, University Hospital of Clermont-Ferrand, F-63000 Clermont-Ferrand, France.

Igor Tauveron (I)

Endocrinology Diabetology and Metabolic Diseases, CHU Clermont-Ferrand, University Hospital of Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
Institut Génétique, Reproduction & Développement (iGReD), CNRS, INSERM, University of Clermont Auvergne, F-63000 Clermont-Ferrand, France.

Reza Bagheri (R)

Department of Exercise Physiology, University of Isfahan, Isfahan 81746-73441, Iran.

Ukadike Chris Ugbolue (UC)

Institute for Clinical Exercise & Health Science, School of Health and Life Sciences, University of the West of Scotland, Glasgow G1 1XW, UK.
Department of Biomedical Engineering, University of Strathclyde, Glasgow G1 1XW, UK.

Valentin Magnon (V)

Physiological and Psychosocial Stress, CHU Clermont-Ferrand, University of Clermont Auvergne, F-63000 Clermont-Ferrand, France.

Jean-Baptiste Bouillon-Minois (JB)

Physiological and Psychosocial Stress, CHU Clermont-Ferrand, University of Clermont Auvergne, F-63000 Clermont-Ferrand, France.
Emergency Department, CHU Clermont-Ferrand, University of Clermont Auvergne, F-63000 Clermont-Ferrand, France.

Valentin Navel (V)

Translational Approach to Epithelial Injury and Repair, GreD, CNRS, INSERM, University of Clermont Auvergne, F-63000 Clermont-Ferrand, France.
Ophthalmology, CHU Clermont-Ferrand, University Hospital of Clermont-Ferrand, F-63000 Clermont-Ferrand, France.

Frédéric Dutheil (F)

Physiological and Psychosocial Stress, CHU Clermont-Ferrand, University of Clermont Auvergne, F-63000 Clermont-Ferrand, France.
Occupational and Environmental Medicine, CHU Clermont-Ferrand, University Hospital of Clermont-Ferrand, F-63000 Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH